{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:57Z","timestamp":1753892037056,"version":"3.41.2"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Eosinophilic bronchiolitis is a rare allergic disorder caused by eosinophilic inflammation in the bronchioles of the lungs. An effective treatment strategy is needed in cases resistant to steroids. However, its pathophysiology remains unclear owing to the limited number of cases. We herein present the case of a 31-year-old man who experienced eosinophilic bronchiolitis with eosinophil ETosis (EETosis) in the mucus plugs. The patient was diagnosed with asthma. His respiratory symptoms worsened with eosinophilia when treated with the standard asthma regimen, including inhaled corticosteroids, long-acting \u03b22-agonist, long-acting muscarinic antagonist, and leukotriene receptor antagonist. Chest computed tomography revealed bronchial wall thickening and centrilobular nodules in the lower lobes of both lungs. Bronchoscopy showed obstruction of the subsegmental bronchus with mucus plugs. Histological analysis demonstrated abundant eosinophils in the mucus plugs. Cytolytic eosinophils together with Charcot\u2013Leyden crystal formations and deposition of major basic proteins were also observed, indicating the occurrence of EETosis. Introduction of benralizumab, an anti-interleukin-5 receptor \u03b1 antibody, successfully controlled the patient\u2019s condition and reduced the amount of systemic corticosteroids administered. Our findings confirm that this antibody strongly decreases airway eosinophils in patients with severe asthma. Thus, benralizumab might be an optimal therapeutic agent for the treatment of mucus plug-forming and\/or EETosis-occurring eosinophilic lung diseases, including eosinophilic bronchiolitis.<\/jats:p>","DOI":"10.3389\/fphar.2021.826790","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T06:55:34Z","timestamp":1642056934000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Case Report: Eosinophilic Bronchiolitis With Eosinophil ETosis in Mucus Plugs Successfully Treated With Benralizumab"],"prefix":"10.3389","volume":"12","author":[{"given":"Hisashi","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Irie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Kuwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kouzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeharu","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1111\/all.14620","article-title":"Adult-Onset Eosinophilic Airway Diseases","volume":"75","author":"Asano","year":"2020","journal-title":"Allergy."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2147\/JAA.S332245","article-title":"Type 2-High Severe Asthma With and Without Bronchiectasis: A Prospective Observational Multicentre Study","volume":"14","author":"Crimi","year":"2021","journal-title":"J. Asthma Allergy."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2004306","DOI":"10.1183\/13993003.04306-2020","article-title":"Novel Mechanisms of Action Contributing to Benralizumab's Potent Anti-Eosinophilic Activity","volume":"21","author":"Dagher","year":"2021","journal-title":"Eur. Respir. J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus Plugs in Patients With Asthma Linked to Eosinophilia and Airflow Obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J. Clin. Invest."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and Safety of Benralizumab for Patients with Severe Asthma Uncontrolled with High-Dosage Inhaled Corticosteroids and Long-Acting \u03b2 2-Agonists (SIROCCO): a Randomised, Multicentre, Placebo-Controlled Phase 3 Trial","volume":"29388","author":"Eugene","year":"2016","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","article-title":"Eosinophil's Role Remains Uncertain as Anti-Interleukin-5 Only Partially Depletes Numbers in Asthmatic Airway","volume":"167","author":"Flood-Page","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.alit.2020.10.002","article-title":"How to Detect Eosinophil ETosis (EETosis) and Extracellular Traps","volume":"70","author":"Fukuchi","year":"2021","journal-title":"Allergol. Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jaci.2013.05.020","article-title":"Effects of Benralizumab on Airway Eosinophils in Asthmatic Patients With Sputum Eosinophilia","volume":"132","author":"Laviolette","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1111\/all.13874","article-title":"Oral Corticosteroid Use, Morbidity and Mortality in Asthma: A Nationwide Prospective Cohort Study in Sweden","volume":"74","author":"Magnus","year":"2019","journal-title":"Allergy."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an Anti-Interleukin-5 Receptor \u03b1 Monoclonal Antibody, as Add-On Treatment for Patients with Severe, Uncontrolled, Eosinophilic Asthma (CALIMA): a Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial","volume":"388","author":"Mark","year":"2016","journal-title":"Lancet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.5415\/apallergy.2021.11.e28","article-title":"Eosinophilic Annular Erythema Showing Eosinophil Cytolytic ETosis Successfully Treated with Benralizumab","volume":"11","author":"Masaki","year":"2021","journal-title":"Asia Pac. Allergy."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"F1000Res637","DOI":"10.12688\/f1000research.24603.2","article-title":"Case Report: Acute Effect of Benralizumab on Asthma Exacerbation without Concomitant Corticosteroid Use","volume":"9","author":"Nolasco","year":"2020","journal-title":"F1000Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.alit.2017.11.007","article-title":"ETosis-Derived DNA Trap Production in Middle Ear Effusion is a Common Feature of Eosinophilic Otitis media","volume":"67","author":"Ohta","year":"2018","journal-title":"Allergol. Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1183\/09031936.00041813","article-title":"Eosinophilic Bronchiolitis: is it a New Syndrome?","volume":"41","author":"Poletti","year":"2013","journal-title":"Eur. Respir. J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.5415\/apallergy.2021.11.e29","article-title":"Eosinophilic Sialoadenitis in a Patient With Severe Asthma: a Case Report","volume":"11","author":"Sano","year":"2021","journal-title":"Asia Pac. Allergy."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e00810","DOI":"10.1002\/rcr2.810","article-title":"Benralizumab Use in Chronic Eosinophilic Pneumonia with Eosinophilic Bronchiolitis and Chronic Airway infection","volume":"9","author":"Takano","year":"2021","journal-title":"Respirology Case Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jaip.2019.10.013","article-title":"Eosinophilic Bronchiolitis Successfully Treated with Mepolizumab","volume":"8","author":"Takeshita","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B20","first-page":"2634","article-title":"Hypereosinophilic Obliterative Bronchiolitis with an Elevated Level of Serum CEA: a Case Report and a Review of the Literature","volume":"19","author":"Tang","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.alit.2020.03.003","article-title":"Rapid Clearance of Mepolizumab-Resistant Bronchial Mucus Plugs in Allergic Bronchopulmonary Aspergillosis with Benralizumab Treatment","volume":"69","author":"Tomomatsu","year":"2020","journal-title":"Allergol. Int."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.826790\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T06:55:37Z","timestamp":1642056937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.826790\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":21,"alternative-id":["10.3389\/fphar.2021.826790"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.826790","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"article-number":"826790"}}